Original Research
Published on 08 Feb 2017
Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2017.00050
- 4,229 views
- 20 citations
